Breaking Finance News

CONMED Corporation (NASDAQ:CNMD) has been downgraded to Buy in a statement by BidaskClub earlier today.

BidaskClub has downgraded CONMED Corporation (NASDAQ:CNMD) to Buy in a statement released on 06/20/2017.

Having a price of $50.79, CONMED Corporation (NASDAQ:CNMD) traded 0.02% higher on the day. With the last stock price up 7.10% from the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.04% over the same period. CNMD has recorded a 50-day average of $49.69 and a two hundred day average of $48.39. Trade Volume was up over the average, with 270,294 shares of CNMD changing hands over the typical 113,405

Recent Performance Chart

CONMED Corporation (NASDAQ:CNMD)

CONMED Corporation has price-earnings ratio of 92.72 with a one year low of $37.60 and a one year high of $52.82 and has a total market value of $0.

A total of 5 equity analysts have issued a report on the company. 2 analysts rating the company a strong buy, two analysts rating the company a buy, 3 brokerages rating the stock a hold, 0 equity analysts rating the company a underperform, and finally zero firms rating the stock a sell with a consensus target price of $45.80.

General Information About CONMED Corporation (NASDAQ:CNMD)

CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company's product lines consist of orthopedic surgery, general surgery and surgical visualization. As of December 31, 2016, the Company's products are distributed domestically directly to over 6,000 hospitals, surgery centers and other healthcare institutions, as well as through medical specialty distributors. The Company's orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. These products are marketed under a range of brands, including Hall, CONMED Linvatec, Concept and Shutt.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *